Sustained generation and survival of antigen-specific CD62Lhigh CD8+ T-cells through in vitro conditioning with interleukin-12: Implications for anti-tumor adoptive immunotherapy.

被引：0
|
作者：
Diaz-Montero, C. Marcela [1 ]
Kadima, Andre [1 ]
El-Naggar, Sabry A. [1 ]
Nath, Narender [1 ]
Cole, David J. [1 ]
Salem, Mohamed L. [1 ]
机构：
[1] Med Univ South Carolina, Charleston, SC 29425 USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5578
引用
收藏
页数：2
相关论文
共 49 条
  • [21] Depletion of conventional CD4+ T cells is required for robust priming and dissemination of tumor antigen-specific CD8+ T cells in the setting of anti-CD4 therapy
    Ramirez, Delaney E.
    Dragnev, Christo P. C.
    Searles, Tyler G.
    Spicer, Nathaniel
    Chen, Tiffany
    Lines, J. Louise
    Hawkes, Aaron R.
    Davis, Wilson L.
    Mohamed, Asmaa
    Shirai, Keisuke
    Phillips, Joseph D.
    Rosato, Pamela C.
    Huang, Yina H.
    Turk, Mary Jo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (11)
  • [22] GENERATION AND EX-VIVO EXPANSION OF ANTIGEN-SPECIFIC CD8+ CYTOTOXIC T-LYMPHOCYTES FOR ADOPTIVE IMMUNOTHERAPY IN CANCER AND CHRONIC VIRAL-INFECTIONS
    PESHWA, MV
    PAGE, LA
    QIAN, L
    YANG, DM
    VANSCHOOTEN, WCA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 48 - BIOT
  • [23] Calcineurin Inhibitors Impede Antigen-Specific Anti-Tumor CD8+ T Cell Responses in Transplantation By Down-Regulating T-bet.
    Rovira, J.
    Renner, P.
    Sabet-Baktach, M.
    Lantow, M.
    Eggenhofer, E.
    Koehl, G.
    Schlitt, H.
    Campistol, J.
    Geissler, E.
    Kroemer, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 36 - 36
  • [24] Calcineurin Inhibitors Impede Antigen-Specific Anti-Tumor CD8+ T Cell Responses in Transplantation By Down-Regulating T-bet
    Rovira, J.
    Renner, P.
    Sabet-Baktach, M.
    Lantow, M.
    Eggenhofer, E.
    Koehl, G.
    Schlitt, H.
    Campistol, J.
    Geissler, E.
    Kroemer, A.
    TRANSPLANTATION, 2014, 98 : 36 - 36
  • [25] Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer Immunotherapy
    Furusawa, Aki
    Reiser, John
    Sadashivaiah, Kavitha
    Simpson, Haley
    Banerjee, Arnob
    JOURNAL OF IMMUNOTHERAPY, 2018, 41 (02) : 53 - 63
  • [26] Antigen priming in the presence of IL-12 selectively enhances the survival of CD62LhiCD8+ T cells and results in superior anti-tumor activity
    Diaz-Montero, C. Marcela
    EL-Naggar, Sabry A.
    Montero, Alberto J.
    Cole, David J.
    Salem, Mohamed L.
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [27] Tissue-resident memory CD8+ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells
    Menares, Evelyn
    Galvez-Cancino, Felipe
    Caceres-Morgado, Pablo
    Ghorani, Ehsan
    Lopez, Ernesto
    Diaz, Ximena
    Saavedra-Almarza, Juan
    Figueroae, Diego A.
    Roa, Eduardo
    Quezada, Sergio A.
    Lladser, Alvaro
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [28] Tissue-resident memory CD8+ T cells amplify anti-tumor immunity by triggering antigen spreading through dendritic cells
    Evelyn Menares
    Felipe Gálvez-Cancino
    Pablo Cáceres-Morgado
    Ehsan Ghorani
    Ernesto López
    Ximena Díaz
    Juan Saavedra-Almarza
    Diego A. Figueroa
    Eduardo Roa
    Sergio A. Quezada
    Alvaro Lladser
    Nature Communications, 10
  • [29] Antigen-specific In Vitro Expansion of Functional Redirected NY-ESO-1-specific Human CD8+ T-Cells in a Cell-free System
    Jakka, Gopinadh
    Schuberth, Petra C.
    Thiel, Markus
    Held, Gerhard
    Stenner, Frank
    Van den Broek, Maries
    Renner, Christoph
    Mischo, Axel
    Petrausch, Ulf
    ANTICANCER RESEARCH, 2013, 33 (10) : 4189 - 4201
  • [30] Combined PD-L1 and TIM3 blockade improves expansion of fit human CD8+ antigen-specific T cells for adoptive immunotherapy
    Lak, Shirin
    Janelle, Valerie
    Djedid, Anissa
    Boudreau, Gabrielle
    Brasey, Ann
    Lisi, Veronique
    Smaani, Ali
    Carli, Cedric
    Busque, Lambert
    Lavallee, Vincent-Philippe
    Delisle, Jean-Sebastien
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2022, 27 : 230 - 245
12345